Kuros Biosciences AG

SIX:KURN.SW

16.78 (CHF) • At close September 6, 2024
Bedrijfsnaam Kuros Biosciences AG
Symbool KURN.SW
Munteenheid CHF
Prijs 16.78
Beurswaarde 604,191,402
Dividendpercentage 0%
52-weken bereik 1.875 - 17.88
Industrie Biotechnology
Sector Healthcare
CEO Dr. Joost D. de Bruijn B.Sc. Ph.D., Ph.D.
Website https://www.kuros.ch

An error occurred while fetching data.

Over Kuros Biosciences AG

Kuros Biosciences AG, a biopharmaceutical company, engages in the commercialization and development of biopharmaceutical products for tissue repair and bone regeneration in the United States, the European Union, and internationally. It operates through Medical Devices, Pharmaceuticals, and Legacy Portfolio. The company's orthobiologics pipeline products include MagnetOs Granules and MagnetOs Putty

Vergelijkbare Aandelen

Newron Pharmaceuticals S.p.A. logo

Newron Pharmaceuticals S.p.A.

NWRN.SW

8 CHF

Santhera Pharmaceuticals Holding AG logo

Santhera Pharmaceuticals Holding AG

SANN.SW

9.22 CHF

Evolva Holding SA logo

Evolva Holding SA

EVE.SW

0.856 CHF

Molecular Partners AG logo

Molecular Partners AG

MOLN.SW

4.77 CHF

Relief Therapeutics Holding AG logo

Relief Therapeutics Holding AG

RLF.SW

2.15 CHF

Financiële Gegevens

Cijfers zijn in miljoenen (CHF)

Cijfers zijn in miljoenen (CHF)